CollaGenex Pharmaceuticals News

“We have to add a lot of people.”

Galderma, a leading dermatological and pharmaceutical company, is expanding its U.S. headquarters at Alliance in far north Fort Worth to accommodate growth, the company said Wednesday. via Fort Worth Star-Telegram

InterMune, Inc. , CompuCredit Corp. and Macrovision Corp. are among the most actively traded companies in Tuesday's pre-market trading among those with market capitalizations under $750 million. via All Stories

CollaGenex Pharmaceuticals Inc . , VirnetX Holding Corp. and IBT Bancorp Inc . were among the new 52-week highs established during Wednesday's trading among companies with market capitalizations or values under ... via All Stories

“I am disappointed that the company is being acquired at this stage in its development before Oracea and CollaGenex's pipeline of new products have reached their full potential”

A large investor in CollaGenex Pharmaceuticals Inc. said Wednesday that he is "disappointed" by the drug maker's pending $420 million acquisition and has not decided how to respond to the tender offer. via International Business Times

Colin Stewart - President and CEO Presentation Operator Welcome to the CollaGenex Pharmaceutical fourth quarter 2007 financial results conference call. via Seeking Alpha

CollaGenex Pharmaceuticals of Newtown Township, which is merging with a Swiss drug company, said Wednesday that it has exceeded expectations and posted a fourth-quarter profit, thanks to rising sales of its ... via PhillyBurbs.com

ATA Inc. , American Realty Investors, Inc. and Quaker Chemical Corp. were among the new 52-week highs established during Tuesday's trading among companies with market capitalizations or values under $750 ... via All Stories

ATA Inc. , AMEN Properties, Inc. and Union Street Acquisition Corp. were among the new 52-week highs established during Monday's trading among companies with market capitalizations or values under $750 million. via All Stories

Debevoise & Plimpton LLP is advising Galderma Pharma S.A. and its U.S. holding company, Galderma Laboratories, Inc., in connection with Galderma's definitive agreement to purchase all of the outstanding shares ... via LawFuel.com

TheSUBWAY.com announces the following stocks to its Action List: National Automation Services, Inc. via Earth Times

CollaGenex Pharmaceutical, Inc. , China Techfaith Wireless Comm. Tech. Ltd. and Converted Organics Inc. via All Stories

“This transaction should be neutral to Galderma's net income in 2008 and accretive as of 2009”

Galderma Pharma, the pharmaceutical company jointly owned by L'Oreal and Nestle, has agreed to acquire CollaGenex Pharmaceuticals. via Women's Wear Daily

Fort Worth-based Galderma Laboratories has agreed to acquire a Pennsylvania-based specialty drug company in a $420 million deal, the companies announced Wednesday.

The skin-care company wants to buy CollaGenex Pharmaceuticals to complement Galderma's product line, President Albert Draaijer said in a written statement.

CollaGenex sells Oracea, a treatment for rosacea, as well as a pair of topical steroids. The company is also developing a psoriasis drug and another that would treat the redness associated with rosacea. Read more

“Galderma clearly believes pretty highly in the col-118 product for it to pay that much”

Galderma could be red in the face if the drug it bought Collagenex Pharmaceuticals for doesn't pan out. via Forbes

Transonic Combustion, Inc. announced today that Khosla Ventures has made an additional investment in the company to become the company - HAWTHORNE, Calif.-- --OSI Systems, Inc. via Business Wire

Nancy C. Broadbent Chief Financial Officer 215-579-7388 or Investors: Financial Dynamics Evan Smith, CFA / Erica Pettit 212-850-5606 / 212-850-5614 CollaGenex Pharmaceuticals, Inc. via PR-inside.com

Overall, clinical results and an array of announcements put health stocks in promising water on hump day -- though there's always an exception. via TheStreet.com

Beta Send us your comments! Enter Company"s name to search for desired profile Premium Company Profiles What's missing from the Overview on the right? Our forthcoming service has integrated three primary ... via Philadelphia Business Journal

Investors are sending shares of CollaGenex Pharmaceuticals, Inc. spiraling downward today after the specialty pharmaceutical company said that results of a Phase 2 study of a drug aimed at the treatment of ... via All Stories

Shares of CollaGenex Pharmaceuticals Inc. fell 22 percent today after the Newtown company said it would end development of its incyclinide drug for treating the skin condition rosacea. via Philly.com